Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Chinese Patent Office
Moodys
Healthtrust
Fuji
US Department of Justice
Citi
McKinsey
Johnson and Johnson

Generated: June 24, 2018

DrugPatentWatch Database Preview

Details for Patent: 7,863,331

« Back to Dashboard

Summary for Patent: 7,863,331
Title:Pharmaceutical composition containing fenofibrate and method for the preparation thereof
Abstract:Pharmaceutical compositions comprising micronized fenofibrate, a surfactant and a binding cellulose derivative as a solubilization adjuvant, wherein said compositions contain an amount of fenofibrate greater than or equal to 60% by weight and methods of producing fenofibrate compositions.
Inventor(s): Criere; Bruno (Gravigny, FR), Suplie; Pascal (Montaure, FR), Chenevier; Philippe (Montreal, CA), Oury; Pascal (Le Chesnay, FR), Rotenberg; Keith S. (Denville, NJ), Bobotas; George (Tarpon Springs, FL)
Assignee: Ethypharm (Saint Cloud, FR)
Application Number:10/677,861
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 7,863,331
Patent Claim Types:
see list of patent claims
Use; Composition; Formulation;

Drugs Protected by US Patent 7,863,331

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Lupin Atlantis ANTARA (MICRONIZED) fenofibrate CAPSULE;ORAL 021695-001 Nov 30, 2004 AB RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial TREATING HYPERCHOLESTEROLEMIAS WITH REDUCTION OF FOOD EFFECT ➤ Try a Free Trial
Lupin Atlantis ANTARA (MICRONIZED) fenofibrate CAPSULE;ORAL 021695-001 Nov 30, 2004 AB RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial TREATING HYPERTRIGLYCERIDEMIAS WITH REDUCTION OF FOOD EFFECT ➤ Try a Free Trial
Lupin Atlantis ANTARA (MICRONIZED) fenofibrate CAPSULE;ORAL 021695-003 Nov 30, 2004 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial TREATING HYPERTRIGLYCERIDEMIAS WITH REDUCTION OF FOOD EFFECT ➤ Try a Free Trial
Lupin Atlantis ANTARA (MICRONIZED) fenofibrate CAPSULE;ORAL 021695-003 Nov 30, 2004 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial TREATING HYPERCHOLESTEROLEMIAS WITH REDUCTION OF FOOD EFFECT ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 7,863,331

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
France99 08923Jul 09, 1999

Non-Orange Book US Patents Family Members for Patent 7,863,331

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,658,212 Pharmaceutical composition containing fenofibrate and method for the preparation thereof ➤ Try a Free Trial
7,101,574 Pharmaceutical composition containing fenofibrate and the preparation method ➤ Try a Free Trial
8,563,042 Pharmaceutical composition containing fenofibrate and method for the preparation thereof ➤ Try a Free Trial
8,529,952 Pharmaceutical composition containing fenofibrate and method for the preparation thereof ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Family Members for US Patent 7,863,331

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 291912 ➤ Try a Free Trial
Austria 341320 ➤ Try a Free Trial
Austria 399006 ➤ Try a Free Trial
Austria 428408 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Chubb
Fuji
Teva
Cipla
Queensland Health
Citi
US Department of Justice
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.